The Caring Ambassadors Lung Cancer Program provides this website to help you and your loved ones understand your disease and some of the health care options available to you.
Knowledge empowers you to ask the necessary questions to become your own best advocate.

The Caring Ambassadors Hepatitis C Program uses a unique approach in our work to address the elimination of viral hepatitis and specifically hepatitis C.
We are honored to serve the community to help eliminate the largest infectious disease outbreak of our time

MY CHOICES© is a tool to help you recognize and act upon what you can control in your health care journey to achieve optimal healing, regardless of the illness you face. It contains elements of a guide book, health planner, journal, and activity book to help orient you to and plan for the journey ahead.

AmazonSmile is a website operate by Amazon with the same products, prices and shopping features as Amazon.com. The difference is that when you shop on AmazonSmile, the AmazonSmile Foundation will donate 0.5% of the purchase price of eligible products. 

The time is now. 71 million people worldwide are living with chronic Hepatitis C right now. It is the largest chronic infectious disease outbreak of our time…and it’s curable. Talk to your doctor about treatment for your Hepatitis C, and don’t take no for an answer

Hey Oregon.  At a time when drug pricing is a top priority for Congress and the White House, we wanted toshare our thoughts on several recent proposals.
Tag Oregon Senators and Congressional delegation and retweet our message!

Weekly News Update.
Caring Ambassadors Program provides 3 weekly news updates covering Lung Cancer News, Hepatitis C News, and My Choices© Update. Receive them delivered weekly to your inbox.

My Choices© Update
Week Ending February 17, 2020

Health Matters: Immune Boosting Foods
“From what you eat, how long you sleep, and how often you exercise—health experts say all can impact your immune system. “Getting adequate sleep, trying to minimize stress, and also not smoking and keeping alcohol consumption more moderate, all tho”

How Does Social Media Shape Your Food Choices?
“For better or worse, your social media friends might be influencing your eating habits, British researchers report.”

Exercise Makes You Happier Than Money, Yale and Oxford Research Suggests
“It’s clear exercise has health benefits both physical and mental. But what if we could prove it has more of an impact on your mental health than your economic status?”

Can T’ai Chi alleviate chronic low back pain in older adults?
“A new study evaluated the feasibility and acceptability of using T’ai Chi to improve chronic low back pain in adults over 65 years of age compared to health education and usual care.”

What’s the Difference Between a Dietitian and a Nutritionist?
“This article reviews the differences between dietitians and nutritionists, what they do, and the education required.”

A happy partner leads to a healthier future
“Michigan State University research found that those who are optimistic contribute to the health of their partners, staving off the risk factors leading to Alzheimer’s disease, dementia and cognitive decline as they grow old together.”

Integrative Oncology: Using Evidence-Informed Medicine to Improve Patient Outcomes and Quality of Life
“Cancer is among the leading causes of death worldwide. New cancer cases per year may rise to 23.6 million by 2030.1 Yet, The American Institute for Cancer Research (AICR) estimates that at least half of cancer cases in the US could be prevented by lifestyle changes.”

What Breathwork Can & Can’t Do For Your Health, According To Experts
“Breathing may seem pretty intuitive — breathe in, breathe out, continue until, well, death. An increasing amount of people are hyping up a more involved form of the practice.”

Could High-Tempo Tunes Help Maximize Your Workout?
“Gyms are bustling with regulars and resolutioners, all working up a sweat. But what’s the secret to an easy, effective workout? It may be in the music.”

‘Light activity’ may lower depression risk in young people
“Researchers already know that physical activity can help lower the risk of depression in adults. A new study suggests that active young adolescents are less likely to experience symptoms of depression by age 18, compared with their sedentary peers.”

Four Ways to Avoid Work Burnout
“Occupational burnout is understood as chronic workplace stress that is not efficiently managed. Here are some key ways to manage your stress levels and avoid burnout.”

How mitochondria respond to exercise, high fat diet
“Dubbed the powerhouses of the cell because they turn nutrients into energy, mitochondria are tiny organelles that live inside the cell and are key to metabolic health. New research offers fresh insights into how they work and what keeps them healthy.”

Hepatitis C News
Week Ending February 17, 2020

Discontinuation of New Hepatitis C Drugs Among Medicare Patients
‘To examine factors associated with discontinuation of new hepatitis C drugs—second-generation direct-acting antivirals (DAAs)—among Medicare beneficiaries with chronic hepatitis C. Study Design: A retrospective analysis using 2014-2016 Medicare claims.’

Study shows benefits of treating opioid addiction, HCV at same time
‘Data from a recent study showed the benefits of initiating opioid agonist therapy and hepatitis C treatment at the same time in patients with opioid use disorder and ongoing injection drug use. Benefits included a high rate of SVR and lower rates of drug use, HIV risk-taking behaviors and overdose.’

In Prison and Out, Untreated HCV Still Poses Burden
‘The era of direct-acting antiviral (DAA) therapy has brought cures for hepatitis C virus (HCV) to hundreds of thousands of people. But some populations still are missing out on HCV therapy entirely or experiencing gaps in care that can render this costly treatment ineffective.’

Maternal Risk Factors Associated with Inadequate Testing and Loss to Follow-up in Infants with Perinatal Hepatitis C Virus Exposure
‘Inadequate testing (IT) and follow-up in infants with perinatal hepatitis C virus (HCV) exposure are challenging. We sought to identify maternal clinical and demographic risk factors that are associated with inadequate testing (IT) and follow-up of perinatally HCV-exposed infants.’

Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: An open-label, single-centre, pilot trial
(https://www.mdlinx.com/journal-summaries/viral-transmission-lung-transplantation-hepatitis-c/2020/02/13/7607339/)
‘By performing this single centre, prospective, open-label, non-randomised trial, researchers evaluated the safety as well as the efficacy of lung transplantation in humans from hepatitis C virus (HCV)-positive donors to HCV-negative recipients following application of ex-vivo lung perfusion (EVLP) plus ultraviolet C (UVC) perfusate irradiation. At Toronto General Hospital, University Health Network (Toronto, ON, Canada), HCV-negative recipients received lungs from HCV-viraemic donors (HCV-positive) during transplantation.’

Most People Who Inject Drugs Miss Opportunities for HIV, HCV Testing
‘More than 90% of people who inject drugs missed opportunities for HIV and hepatitis C (HCV) testing, according to an analysis of a nationwide insurance database for claims paid between 2010 and 2017. The study, published in The Journal of Infectious Diseases, examined records for 844,242 people who inject drugs (PWID), finding that 8.6% were tested for HIV and 7.7% were tested for HCV within 1 year of a clinical encounter consistent with injection drug use.’

Some State Medicaid Programs Still Block or Limit Hep C Drugs
‘More than four years ago, CMS warned state Medicaid programs that they may be violating federal law by restricting access to antiviral hepatitis C drugs such as Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) because they are categorized as “medically necessary.” Despite that red flag, a new analysis has found that some states continue to deny treatments to beneficiaries, although others are gradually making the drugs more accessible.’

Lung Cancer News
Week Ending February 17, 2020

Pilot telemedicine program to serve lung nodule patients in Bibb County
“Some lung nodules identified on radiographic studies need specialized follow-up to ensure early detection and treatment of lung cancer. Patients identified with lung nodules will now be able to receive care from University of Alabama at Birmingham physicians via telemedicine.”

Intratumoral heterogeneity may be responsible for chemotherapy resistance in patients with small cell lung cancer
“Small cell lung cancer (SCLC) accounts for 14% of all lung cancers and is often rapidly resistant to chemotherapy, resulting in poor clinical outcomes. Treatment has changed little for decades, but a study at The University of Texas MD Anderson Cancer Center found that chemotherapy results in increased heterogeneity within the tumor, leading to the evolution of multiple resistance mechanisms.”

FDA approves Pemfexy injection for lung cancer
“FDA has granted approval Pemfexy, a pemetrexed injection ready-to-dilute formulation for locally advanced or metastatic nonsquamous non-small cell lung cancer in combination with cisplatin and other indications.”

Lung Cancer Mortality Suggested to be Significantly Lower with Volume CT
“The NELSON trial, published in The New England Journal of Medicine, suggested that in high risk individuals, lung cancer mortality was found to be significantly lower among participants who underwent volume computed tomographic (CT) screening compared to those who underwent no screening.”

‘Viable’ Responses With BRAF Inhibitor in Lung Cancer
“Only active against V600 mutations, French study shows
Single-agent BRAF inhibition produced viable objective responses in patients with non-small-cell lung cancer (NSCLC) and certain BRAF mutations, a phase II trial showed.”

Flu Shot May Trigger Beneficial Immune Response Against Lung Cancer
“Injecting malignant tumors with an influenza vaccine might trigger an immune response, which could reduce tumor growth, according to a study conducted by researchers at Rush University Medical Center.”